TABLE 1.
Clinicopathological characteristics of six ovarian cancer patients that were treated with neoadjuvant chemotherapy.
| Case no. | Age (Year) | FIGO stage | Right (R) and left (L) ovary | Histological diagnosis | Treatment | Clinical response to therapy |
|---|---|---|---|---|---|---|
| 1 | 38 | III | R | HGSOC | Carboplatin + paclitaxel | Progressive disease |
| 2 | 78 | IV | R | HGSOC | Carboplatin + paclitaxel | Responsive |
| 3 | 45 | II | R | HGSOC | Carboplatin + paclitaxel | Responsive |
| 4 | 50 | III | R and L | HGSOC | Carboplatin + paclitaxel | Progressive disease |
| 5 | 54 | III | R and L | HGSOC | Carboplatin + paclitaxel | Progressive disease (death) |
| 6 | 68 | IV | R | HGSOC | Carboplatin + paclitaxel | Progressive disease (death) |